Best Value Stocks to Buy for August 28th

Zacks screens three buy-ranked, value-tilted stocks—Qifu Technology (QFIN), RCM Technologies (RCMT), and Cerence (CRNC). Consensus earnings estimates rose over the last 60 days by 17.9% for QFIN, 2.2% for RCMT, and 15.0% for CRNC, alongside notably discounted valuation multiples (P/E of 5.21 vs 12.60 industry for QFIN; 8.84 vs 15.40 for RCMT; 3.51 vs 67.70 for CRNC). Overall, the setup is supportive for stock-specific upside rather than broad market impact.

Analysis

This screen is more a factor signal than a catalyst-rich setup. The only name with a credible path to multiple expansion is QFIN: when estimate momentum and a depressed valuation coincide, the stock can rerate quickly if credit performance stays stable and management continues converting earnings into buybacks. The second-order winner is likely the stronger balance-sheet/funding-cost player in China credit tech, while weaker lenders lose share as distribution and underwriting get more expensive.

CRNC reads differently: the low multiple looks like a durability discount, not simple cheapness. In automotive software, OEMs can commoditize voice/assistant layers by pushing functionality into native infotainment stacks or broader AI ecosystems, so any re-rating needs evidence that design wins translate into recurring margin, not just one-time license optimism. If margins don’t inflect in the next 1-2 quarters, the “AI beneficiary” narrative can unwind fast.

RCMT is the most neutral of the three: it can work if enterprise and public-sector spending stays resilient, but it lacks the same estimate acceleration and may simply be a slow-growth compounder. Contrarian take: the market is likely overpaying for the “value + AI” label on CRNC and underpricing how much of QFIN’s discount could close if revisions keep rising. The screen is weakly positive overall, but the tradeable expression is selective rather than broad beta to cheap stocks.

Key Decisions for Investors

• Initiate a starter long QFIN on any pullback into the next earnings window; target a 1-3 month rerating if estimate revisions stay positive. Stop/exit if delinquency commentary or policy headlines indicate a renewed credit-quality inflection.
• Avoid chasing CRNC on the screen alone; if owned, consider trimming or hedging with puts into the next 1-2 quarters unless OEM design-win conversion and gross margin stabilization are visible. Thesis breaks if revenue quality does not improve despite the AI narrative.
• Use a long QFIN / short CRNC pair to isolate quality-versus-optionality: QFIN has cleaner earnings momentum, while CRNC needs proof of durable monetization. The pair should work best over 1-3 months if the market continues rewarding revisions over story stocks.
• Keep RCMT on a watchlist rather than a conviction trade; enter only if upcoming prints confirm margin resilience and backlog stability. If guidance softens, the low multiple is likely justified and upside will be limited.